(Q34371480)

1 August 2017

title

The preclinical development of bicalutamide: pharmacodynamics and mechanism of action (English)

1 reference

1 August 2017

1 reference

1 reference

Furr BJ

1

1 reference

1 August 2017

Tucker H

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

1 August 2017

1 reference

1 August 2017

volume

47

1 reference

1 August 2017

issue

1A Suppl

1 reference

1 August 2017

page(s)

13-25; discussion 29-32

1 reference

1 August 2017

cites work

Cancer statistics, 1992

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

STUDIES ON PROSTATIC CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

The Effect of the Steroidal Androgen Receptor Antagonist, Win 49,596, on the Prostate and Testis of Beagle Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Studies on the mechanism of action of win 49596: A steroidal androgen receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Liver tumours in women on oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Biological studies on an anti-androgen (SH 714)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Flutamide therapy for advanced prostatic cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Disposition of a New, Nonsteroid, Antiandrogen, α,α,α-Trifluoro-2-methyl-4′-nitro-m-propionotoluidide (Flutamide), in Men Following a single Oral 200 mg Dose

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Ocular toxicity of Anandron in patients treated for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Ocular toxicity of anandron

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: inhibition of cat expression by anti-androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R1881 binding to the prostatic androgen receptor and [3H]5α-dihydrotestosterone and [3H]cortisol binding to plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Antiandrogen ICI 176,334 does not prevent development of androgen insensitivity in S115 mouse mammary tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Evaluation of a peripherally selective antiandrogen (Casodex) as a tool for studying the relationship between testosterone and spermatogenesis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Microheterogeneity of pituitary follicle-stimulating hormone in male rats: differential effects of the chronic androgen deprivation induced by castration or androgen blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Biodegradable polymers for the sustained release of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

Pathological and morphometric assessment of testicular parameters in patients with metastatic prostate cancer following treatment with either the antiandrogen Casodex (ZM176,334) or bilateral orchidectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

The pharmacokinetics of Casodex in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2980003-3

7 January 2021

10.1016/S0090-4295(96)80003-3

Identifiers

DOI

1 reference

1 August 2017

1 reference